Tag: symposiuim

Andarix Pharmaceuticals CEO to Present on Targeted Radiometal Therapeutics for Lung Cancer at International Symposium on Bioorganometallic Chemistry 2025

Aug 21, 2025

—

by

cadams

in Uncategorized

conference, international, lung cancer, oncology, personalized medicine, radiotherapy, symposiuim, targeted therapy

Presentation underscores Andarix’s leadership in advancing radiometal-based cancer therapeutics and highlights partnering and investment opportunities in a rapidly growing field. FOR IMMEDIATE RELEASE August 25, 2025 Contact: Andarix Pharmaceuticals 617-957-9858 info@andarix.com Boston, MA – August 25, 2025 – Andarix Pharmaceuticals, a clinical‑stage biopharmaceutical company developing next‑generation targeted radiotherapeutics for oncology, today announced that Chief Executive Officer Chris…